{
  "pmcid": "6509049",
  "sha256": "f2c0c77bc9ec60f98005b41e19a01f1a37d021b8d15932116572fc2b6cfe7814",
  "timestamp_utc": "2025-11-09T22:50:54.582653+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.904440470107307,
    "reading_ease": 0.3467680122636807,
    "word_count": 206
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Hyperinsulinemic Normoglycemia in Cardiac Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "dual-center, parallel-group, superiority trial randomized cardiac surgical patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "cardiac surgical patients at the Cleveland Clinic and Royal Victoria Hospital"
      },
      "Intervention": {
        "score": 2,
        "evidence": "hyperinsulinemic normoglycemia (fixed high-dose insulin and variable glucose infusion targeting 80–110 mg·dL−1) or standard glycemic management (low-dose insulin targeting glucose >150 mg·dL−1)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study tested whether it reduces 30-day mortality and morbidity post-cardiac surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was a composite of 30-day mortality, mechanical circulatory support, infection, renal or neurologic morbidity."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was computer-generated with allocation concealment."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 1,439 patients were randomized (709 to hyperinsulinemic normoglycemia, 730 to standard management)."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was intention-to-treat."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The primary outcome occurred in 49 (6.9%) patients in the hyperinsulinemic group versus 82 (11.2%) in the standard group (P<0.0085); relative risk 0.62 (95% CI 0.39, 0.97), P=0.0043."
      },
      "Harms": {
        "score": 1,
        "evidence": "Severe hypoglycemia (<40 mg·dL−1) occurred in 6 (0.9%) patients."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source]."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}